BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5396484)

  • 1. Preliminary safety studies with calcium elenolate, an antiviral agent.
    Elliott GA; Buthala DA; DeYoung EN
    Antimicrob Agents Chemother (Bethesda); 1969; 9():173-6. PubMed ID: 5396484
    [No Abstract]   [Full Text] [Related]  

  • 2. Route-dependent different relations between acute and subacute toxicity of the potential antiviral agent benzoxazolyl-2-formyl-S-ethyl-isothiosemicarbazone in mice.
    Amlacher R
    Pharmazie; 1985 Feb; 40(2):132-3. PubMed ID: 3839080
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
    Coppi G; Bonardi G; Perego R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:234-6. PubMed ID: 5067199
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro antiviral activity of calcium elenolate.
    Renis HE
    Antimicrob Agents Chemother (Bethesda); 1969; 9():167-72. PubMed ID: 5396483
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo evaluations of tilorone hydrochloride against Semliki Forest virus.
    Krueger RF; Mayer GD; Yoshimura S; Ludwig KA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():486-90. PubMed ID: 5521373
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of myxoviruses by calcium elenolate.
    Renis HE
    Antimicrob Agents Chemother; 1975 Aug; 8(2):194-9. PubMed ID: 1180544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemistry and toxicology of a new antiviral agent: N-(1-adamantyl)-2-(2-dimethylamino-ethoxy)-acetamide-HCl.1].
    Peteri D; Sterner W
    Arzneimittelforschung; 1973 Apr; 23(4):577-81. PubMed ID: 4740238
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridine.
    Robinson Y; Gerry N; Brownsill RD; Vose CW
    Biomed Mass Spectrom; 1984 Apr; 11(4):199-201. PubMed ID: 6733256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical toxicology studies with the new dopamine agonist pergolide. Acute, subchronic, and chronic evaluations.
    Francis PC; Carlson KH; Owen NV; Adams ER
    Arzneimittelforschung; 1994 Mar; 44(3):278-84. PubMed ID: 8192691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of the antiviral agent calcium elenolate.
    Heinze JE; Hale AH; Carl PL
    Antimicrob Agents Chemother; 1975 Oct; 8(4):421-5. PubMed ID: 53031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A preclinical trial of iodoantipyrine safety].
    Saratikov AS; Novozheeva TP; Livshits NS; Burchenkova FI; Kadychagova NG; Akhmedzhanov RR; Bashirova LV; Eremina AA; Potapova GV
    Eksp Klin Farmakol; 1998; 61(2):57-9. PubMed ID: 9621178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicity of triazavirin, a novel Russian antiinfluenza chemotherapeutic].
    Loginova SIa; Borisevich SV; Rusinov VL; Ulomskiĭ UN; Charushin VN; Chupakhin ON
    Antibiot Khimioter; 2012; 57(11-12):8-10. PubMed ID: 23700930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.
    Buckwold VE; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):62-70. PubMed ID: 16867173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of a thiazolobenzimidazole active against human immunodeficiency virus-1.
    el Dareer SM; Tillery KF; Rose LM; Posey CF; Struck RF; Stiller SW; Hill DL
    Drug Metab Dispos; 1993; 21(2):231-5. PubMed ID: 8097690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
    Coulombe RA; Huie JM; Sharma RP; Huggins JW
    Drug Metab Dispos; 1993; 21(4):555-9. PubMed ID: 8104112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
    Chung HJ; Lee JH; Woo SJ; Park HK; Koo CH; Lee MG
    Biopharm Drug Dispos; 2007 May; 28(4):187-97. PubMed ID: 17377948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron supplementation by intraperitoneal injection eliminates the accumulation of hepatic copper induced by excess calcium in rats.
    Takasugi S; Matsui T; Yano H
    Br J Nutr; 2009 Jul; 102(2):258-63. PubMed ID: 19138444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of statolon-induced interferon on rabies virus infection in mice.
    Soave OA
    Am J Vet Res; 1968 Jul; 29(7):1507-8. PubMed ID: 5690788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.